Clinical Trial: Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07811271) titled 'Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers' on Sept. 03.

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of BG-C9074 with bevacizumab (Arm A) versus bevacizumab monotherapy (Arm B) in adults with epithelial ovarian, fallopian tube, or primary peritoneal cancers who have not progressed after firstline platinum-based chemotherapy plus bevacizumab.

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Interventio...